Correlation and coexpression of HIFs and NOTCH markers in NSCLC

Anticancer Research

Volumn 31, Issue 5, 2011, Pages 1603-1606

  Andersen, Sigve ^a,b   Donnem, Tom ^a,b   Al Saad, Samer ^a,b   Al Shibli, Khalid ^a,c   Stenvold, Helge ^a,b   Busund, Lill Tove ^a,b   Bremnes, Roy M ^a,b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^c NORDLAND HOSPITAL   (Norway)

Author keywords

HIF; Lung cancer; NOTCH; NSCLC; Prognostic factors

Indexed keywords

CARBONATE DEHYDRATASE IX; DELTA LIKE 4; GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 2ALPHA; JAGGED1; LACTATE DEHYDROGENASE; LACTATE DEHYDROGENASE 5; NOTCH1 RECEPTOR; NOTCH4 RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; FOLLOW UP; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STROMA CELL;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RECEPTORS, NOTCH; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 79958146244     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Rizzo P, Osipo C, Foreman K, Golde T, Osborne B and Miele L: Rational targeting of Notch signaling in cancer. Oncogene 27: 5124-5131, 2008.
2. Semenza GL: Evaluation of HIF-1 inhibitors as anticancer agents. Drug Discov Today 12: 853-859, 2007.
3. Radtke F and Raj K: The role of Notch in tumorigenesis: oncogene or tumour suppressor? Nat Rev Cancer 3: 756-767, 2003.
4. Gustafsson MV, Zheng X, Pereira T, Gradin K, Jin S, Lundkvist J, Ruas JL, Poellinger L, Lendahl U and Bondesson M: Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev Cell 9: 617-628, 2005. (Pubitemid 41555144)
5. Andersen S, Eilertsen M, Donnern T, Al-Shibli K, Al-Saad S, Busund LT and Bremnes RM: Diverging prognostic impacts of hypoxic markers according to NSCLC histology. Lung Cancer 2010 [Epub ahead of print].
6. Donnern T, Andersen S, Al Shibli K, Al Saad S, Busund LT, and Bremnes RM: Prognostic impact of Notch ligands and receptors in nonsmall cell lung cancer: coexpression of Notch-1 and vascular endothelial growth factor-A predicts poor survival. Cancer 24: 5676-5685, 2010.
7. Jubb AM, Turley H, Moeller HC, Steers G, Han C, Li JL, Leek R, Tan EY, Singh B, Mortensen NJ, Noguera-Troise I, Pezzella F, Gatter KC, Thurston G, Fox SB and Harris AL: Expression of delta-like ligand 4 (D114) and markers of hypoxia in colon cancer. Br J Cancer 101: 1749-1757, 2009.
8. Chen J, Imanaka N, Chen J and Griffin JD: Hypoxia potentiates Notch signaling in breast cancer leading to decreased E-cadherin expression and increased cell migration and invasion. Br J Cancer 102: 351-360, 2010.
9. Bedogni B, Warneke JA, Nickoloff BJ, Giaccia AJ and Powell MB: Notch1 is an effector of Akt and hypoxia in melanoma development. J Clin Invest 118: 3660-3670, 2008.
10. Chen Y, De Marco MA, Graziani I, Gazdar AF, Strack PR, Miele L and Bocchetta M: Oxygen concentration determines the biological effects of NOTCH-1 signaling in adenocarcinoma of the lung. Cancer Res 67: 7954-7959, 2007. (Pubitemid 47395124)
11. Kaluz S, Kaluzova M, Liao SY, Lerman M and Stanbridge EJ: Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: A one transcription factor (HIF-1) show? Biochim Biophys Acta 1795: 162-172, 2009.
12. Uchida T, Rossignol F, Matthay MA, Mounier R, Couette S, Clottes E and Clerici C: Prolonged Hypoxia Differentially Regulates Hypoxia-inducible Factor (HIF)-1α and HIF-2a Expression in Lung Epithelial Cells: Implication of Natural Antisense HIF-1α. J Biol Chem 279: 14871-14878, 2004.
13. Le QT, Chen E, Salim A, Cao H, Kong CS, Whyte R, Donington J, Cannon W, Wakelee H, Tibshirani R, Mitchell JD, Richardson D, O'Byrne KJ, Koong AC and Giaccia AJ: An Evaluation of Tumor Oxygenation and Gene Expression in Patients with Early Stage Non-Small Cell Lung Cancers. Clin Can Res 12: 1507-1514, 2006.